1. Composition containing L.johnsonii Lal (NCC533, No. CNCM 1-1225), intended for the treatment and prevention of disorders associated with the immune system, including infections. The composition according to claim 1, where at least 90%, for example at least 95% or all L.johnsonii Lal (NCC533, No. CNCM 1-1225) are non-replicating. The composition of claim 2, wherein the non-replicating L. johnsonii Lal (NCC533, No. CNCM 1-1225) are thermally inactivated, preferably by treatment with a temperature of at least about 70 ° C. The composition according to claim 3, where the heat treatment is carried out for at least 10 s. The composition according to claim 1, where L. johnsonii Lal (NCC533, No. CNCM 1-1225) is transferred to a state in which they become non-replicating at a temperature of 110 ° to 140 ° for 5-30 seconds. The composition according to claim 1, which contains an amount of L. johnsonii Lal (NCC5 33, No. CNCM 1-1225) corresponding to about 10 to 10 CFU per daily dose. The composition according to claim 1, which contains from about 0.005 mg to 1000 mg of L. johnsonii Lal (NCC533, No. CNCM 1-1225) per daily dose. The composition of claim 1, which is selected from the group consisting of food compositions, food products, including animal feed, drinks, balanced nutrition formulations, nutritional supplements, nutraceuticals, food additives, pharmaceutical compositions, cosmetic compositions, topical compositions, and medicines. 9. The composition according to any one of claims 1 to 8, wherein the disorder associated with the immune system is selected from the group consisting of infections, in particular bacterial, viral, fungal and / or parasitic infections, inflammation, deficiency of phagocytes, defect of the epithelial barrier, immune immaturity systems, bacterial overgrowth in the small intestine (SIBO), and combinations thereof1. Композиция, содержащая L.johnsonii Lal (NCC533, № CNCM 1-1225), предназначенная для лечения и предотвращения нарушений, связанны
